T1	Participants 87 125	patients with gynecologic malignancies
T2	Participants 319 357	patients with gynecologic malignancies
T3	Participants 367 517	Ninety-three consecutive patients with gynecologic pelvic malignancies who underwent surgery including pelvic or pelvic and paraaortic lymphadenectomy
T4	Participants 944 955	93 patients
